Salvaging Locoregional Recurrence with Radiotherapy after Surgery in Early Cervical Cancer

Clinical Oncology

Volumn 19, Issue 10, 2007, Pages 763-768

  Jain, P ^a   Hunter, R D ^a   Livsey, J E ^a   Coyle, C ^b   Swindell, R ^a   Davidson, S E ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

Morbidity; radiotherapy; recurrent cervical cancer; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORBIDITY; PRIORITY JOURNAL; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VAGINAL VAULT PROLAPSE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 35548988820     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.08.015     Document Type: Article

References (30)

1. Grisaru D., Covens A., Chapman B., et al. Does histology influence prognosis in patients with early-stage cervical carcinoma?. Cancer 92 (2001) 2999-3004
2. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., and Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38 (1990) 352-357
3. Zaino R.J., Ward S., Delgado G., et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 69 (1992) 1750-1758
4. Burghardt E., Baltzer J., Tulusan A.H., and Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 70 (1992) 648-655
5. Stehman F.B., Bundy B.N., DiSaia P.J., Keys H.M., LArson J.E., and Fowler W.C. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67 (1991) 2776-2785
6. Ho C.-M., Chien T.-Y., Huang S.-H., Wu C.-J., Shih B.-Y., and Chang S.-C. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 93 (2004) 458
7. Potter M.E., Alvarez R.D., Gay F.L., Shingleton H.M., Soong S.-J., and Hatch K.D. Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol 37 (1990) 74
8. Ayhan A., Al R.A., Baykal C., Demirtas E., Ayhan A., and Yuce K. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Int J Gynecol Cancer 14 (2004) 286-292
9. Barter J.F., Soong S.J., Shingleton H.M., Hatch K.D., and Orr Jr. J.W. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 32 (1989) 292-296
10. Magrina J.F. Complications of irradiation and radical surgery for gynecologic malignancies. Obstet Gynecol Surv 48 (1993) 571-575
11. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26 (1993) 195-202
12. Hunter R.D., and Davidson S.E. Low dose-rate brachytherapy for treating cervix cancer: changing dose rate. In: Joslin C.A.F., Flynn A., and Hall E.J. (Eds). Principles and practice of brachytherapy using afterloading systems (2001), Arnold Press, London 343-353
13. Friedlander M., and Grogan M. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 7 (2002) 342-347
14. Ijaz T., Eifel P.J., Burke T., and Oswald M.J. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol 70 (1998) 241-246
15. Kinney W.K., Egorshim E.V., Ballard D.J., and Podratz K.C. Long-term survival and sequelae after surgical management of invasive cervical carcinoma diagnosed at the time of simple hysterectomy. Gynecol Oncol 44 (1992) 24-27
16. Mundt A.J., Roeske J.C., Lujan A.E., et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 82 (2001) 456
17. Smaniotto D., D'Agostino G., Luzi S., et al. Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome. Tumori 91 (2005) 295-301
18. Windschall A., Ott O.J., Sauer R., and Stmad V. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma. Strahlenther Onkol 181 (2005) 545
19. Singh A.K., Grigsby P.W., Rader J.S., Mutch D.G., and Powell M.A. Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. Int J Radiat Oncol Biol Phys 61 (2005) 450
20. Miglietta L., Franzone P., Centurioni M.G., et al. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer. Oncology 70 (2006) 19-24
21. Malfetano J., Keys H., Kredentser D., Cunningham M., Kotlove D., and Weiss L. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 71 (1993) 3703-3706
22. Tutt A.N., Lodge N., and Blake P.R. Palliative chemotherapy in recurrent carcinoma of the cervix: an audit of the use of ifosfamide and review of the literature. Int J Gynecol Cancer 9 (1999) 12-17
23. Mutch D.G., and Bloss J.D. Gemcitabine in cervical cancer. Gynecol Oncol 90 2 Pt 2 (2003) S8-S15
24. Eralp Y., Saip P., Sakar B., et al. Efficacy of cisplatin and cyclophosphamide combination for recurrent and metastatic carcinoma of the uterine cervix. Eur J Gynaecol Oncol 24 (2003) 323-326
25. Tan R., Chung C.H., Liu M.T., Lai Y.L., and Chang K.H. Radiotherapy for postoperative recurrent uterine cervical carcinoma. Acta Oncol 30 (1991) 353-356
26. Pedersen D., Bentzen S.M., and Overgaard J. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29 (1994) 941-952
27. Davidson S.E., Burns M.P., Routledge J.A., Swindell R., Bentzen S.M., and West C.M. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary. Radiother Oncol 69 (2003) 195-200
28. Pavy J.J., Denekamp J., Letschert J., et al., EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35 (1995) 11-15
29. Routledge J.A., Burns M.P., Swindell R., Khoo V.S., West C.M., and Davidson S.E. Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int J Radiat Oncol Biol Phys 56 (2003) 502-510
30. Denton A.S., Bond S.J., Matthews S., Bentzen S.M., and Maher E.J. Treatment-related morbidity and hospital league tables: experience from a national audit of radiotherapy-induced morbidity in cervical carcinoma. Clin Oncol (R Coll Radiol) 14 (2002) 40-42